IPO Trending
CURISSME / NSEListed
Curis Lifesciences

Curis Lifesciences Limited, founded in 2010, is a pharmaceutical company engaged in developing, manufacturing, and distributing a wide range of medicines. It produces pharmaceutical products for both domestic and global markets through loan license, contract manufacturing, and its own brand marketing. The company serves over 100 corporate clients under contract manufacturing and two clients for its own brands in Yemen and Kenya. Its product range includes tablets, capsules, oral liquids, external preparations, and sterile ophthalmic ointments. The company operates a modern manufacturing facility in Sanand, Gujarat, maintaining strict quality standards, and as of July 31, 2025, it employs 95 permanent staff.

₹120 - ₹12874.47x sub
Listed Price₹146.10
Listing Gain+14.14%

Subscription Status

74.47xTotal Demand
Updated 20 Oct 2026, 01:30 AM
QIB96.17x
🔥 Blockbuster Sizzling Demand!Offered: 4,09,000 sh
Nib115.81x
🔥 Blockbuster Sizzling Demand!Offered: 3,08,000 sh
Hnis(10l +)143.26x
🔥 Blockbuster Sizzling Demand!Offered: 2,06,000 sh
Hnis (2-10l)60.38x
🔥 Blockbuster Sizzling Demand!Offered: 1,02,000 sh
Retail44.28x
🔥 Blockbuster Sizzling Demand!Offered: 7,16,000 sh
CategoryOfferedAppliedTimes
QIB4,09,0003,93,35,00096.17x
Nib3,08,0003,56,71,000115.81x
Hnis(10l +)2,06,0002,95,12,000143.26x
Hnis (2-10l)1,02,00061,59,00060.38x
Retail7,16,0003,17,06,00044.28x

Segment Subscription Demand

Segment / CategoryDemand (Shares)Offered (Shares)Times Sub.
QIB503.495.2496.09x
Fiis187.280Open
Fis10.340Open
Others305.870Open
Retail405.849.1644.31x
Nib456.593.94115.89x
Hnis 2+78.841.3160.18x
Hnis 10+377.752.64143.09x

Application-wise Breakup

CategoryReservedAppliedTimes Sub.
QIB044Open
Nib05,576Open
Retail35815,85344.28x
Hnis(10l +)693,60552.25x
Hnis (2-10l)341,97157.97x
Bidding status cross-verified with live IPO subscription numbers ↗BSE & NSE Bidding Portal Feed

About Curis Lifesciences IPO Subscription Demand

Live subscription status and bidding analysis for Curis Lifesciences (CURIS) IPO. The issue is subscribed 74.47x overall across Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII/HNI), and Retail Individual Investors (RII). Check real-time grey market demand on our GMP Tracker or review full issue details, lot size, and price band on the IPO Details Page.

Frequently Asked Questions